| [1] |
Tan S Y, Zhou J B, Veang T, et al. Global, regional, and national burden of atrial fibrillation and atrial flutter from 1990 to 2021: sex differences and global burden projections to 2046-a systematic analysis of the Global Burden of Disease Study 2021[J]. Europace, 2025, 27(2): euaf027. DOI: 10.1093/europace/euaf027.
|
| [2] |
Heeringa J, Van Der Kuip D A M, Hofman A, et al. Prevalence, incidence and lifetime risk of atrial fibrillation: the Rotterdam study[J]. Eur Heart J, 2006, 27(8): 949-953.
|
| [3] |
Benjamin E J, Virani S S, Callaway C W, et al. Heart disease and stroke statistics-2018 update: a report from the American heart association[J]. Circulation, 2018, 137(12): e67-e492.
|
| [4] |
Roth G A, Mensah G A, Johnson C O, et al. Global burden of cardiovascular diseases and risk factors, 1990-2019: update from the GBD 2019 study[J]. J Am Coll Cardiol, 2020, 76(25): 2982-3021. DOI: 10.1016/j.jacc.2020.11.010.
|
| [5] |
Van Staa T P, Setakis E, Di Tanna G L, et al. A comparison of risk stratification schemes for stroke in 79 884 atrial fibrillation patients in general practice[J]. J Thromb Haemost, 2011, 9(1): 39-48. DOI: 10.1111/j.1538-7836.2010.04085.x.
|
| [6] |
Souresrafil A, Abutorabi A, Peighambari M M, et al. Cost-effectiveness of new oral anticoagulants for the prevention of stroke in patients with atrial fibrillation in low and middle-income countries: a systematic review[J]. Med J Islam Repub Iran, 2022, 36: 6. DOI: 10.47176/mjiri.36.6.
|
| [7] |
Lippi G, Sanchis-Gomar F, Cervellin G. Global epidemiology of atrial fibrillation: an increasing epidemic and public health challenge[J]. Int J Stroke, 2021, 16(2): 217-221. DOI: 10.1177/1747493019897870.
|
| [8] |
Thrall G, Lane D, Carroll D, et al. Quality of life in patients with atrial fibrillation: a systematic review[J]. Am J Med, 2006, 119(5): 448.e1-e19. DOI: 10.1016/j.amjmed.2005.10.057.
|
| [9] |
Brundel B J J M, Ai X, Hills M T, et al. Atrial fibrillation[J]. Nat Rev Dis Primers, 2022, 8: 21. DOI: 10.1038/s41572-022-00347-9.
|
| [10] |
January C T, Wann L S, Calkins H, et al. 2019 AHA/ACC/HRS focused update of the 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American college of cardiology/American heart association task force on clinical practice guidelines and the heart rhythm society in collaboration with the society of thoracic surgeons[J]. Circulation, 2019, 140(2): e125-e151. DOI: 10.1161/CIR.0000000000000665
|
| [11] |
Hindricks G, Potpara T, Dagres N, et al. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): the task force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC[J]. Eur Heart J, 2021, 42(5): 373-498. DOI: 10.1093/eurheartj/ehaa612.
|
| [12] |
|
| [13] |
Nguyen B O, Weberndorfer V, Crijns H J, et al. Prevalence and determinants of atrial fibrillation progression in paroxysmal atrial fibrillation[J]. Heart, 2022, 109(3): 186-194.
|
| [14] |
Middeldorp M E, Sandhu R K, Mao J, et al. Risk factors for the development of new-onset persistent atrial fibrillation: subanalysis of the VITAL study[J]. Circ Arrhythm Electrophysiol, 2023, 16(12): 651-662. DOI: 10.1161/CIRCEP.123.012334.
|
| [15] |
Patel V A, Bushi G, Balaraman A K, et al. Left ventricular ejection fraction as a prognostic marker in atrial fibrillation management[J]. Int J Surg Open, 2024, 62(6): 830-832. DOI: 10.1097/io9.0000000000000217.
|
| [16] |
Del Pinto R, Ferri C. Inflammation-accelerated senescence and the cardiovascular system: mechanisms and perspectives[J]. Int J Mol Sci, 2018, 19(12): 3701. DOI: 10.3390/ijms19123701.
|
| [17] |
Choi D H, Kang S H, Song H. Mean platelet volume: a potential biomarker of the risk and prognosis of heart disease[J]. Korean J Intern Med, 2016, 31(6): 1009-1017. DOI: 10.3904/kjim.2016.078.
|
| [18] |
Ha S I, Choi D H, Ki Y J, et al. Stroke prediction using mean platelet volume in patients with atrial fibrillation[J]. Platelets, 2011, 22(6): 408-414. DOI: 10.3109/09537104.2011.560306.
|
| [19] |
Bayar N, Arslan S, Cagirci G, et al. Usefulness of mean platelet volume for predicting stroke risk in paroxysmal atrial fibrillation patients[J]. Blood Coagul Fibrinolysis, 2015, 26(6): 669-672. DOI: 10.1097/MBC.0000000000000334.
|
| [20] |
Turfan M, Erdogan E, Ertas G, et al. Usefulness of mean platelet volume for predicting stroke risk in atrial fibrillation patients[J]. Blood Coagul Fibrinolysis, 2013, 24(1): 55-58.
|
| [21] |
Misialek J R, Lopez F L, Lutsey P L, et al. Serum and dietary magnesium and incidence of atrial fibrillation in whites and in African Americans—Atherosclerosis Risk in Communities (ARIC) study[J]. Circ J, 2013, 77(2): 323-329.
|
| [22] |
Ding M Z, Viet N N, Gigante B, et al. Elevated uric acid is associated with new-onset atrial fibrillation: results from the Swedish AMORIS cohort[J]. J Am Heart Assoc, 2023, 12(3): e027089.
|
| [23] |
Lee H J, Lee S R, Choi E K, et al. Low lipid levels and high variability are associated with the risk of new-onset atrial fibrillation[J]. J Am Heart Assoc, 2019, 8(23): e012771.
|
| [24] |
Li G Y, Elimam A M, Lo L W, et al. Factors predicting the progression from paroxysmal to persistent atrial fibrillation despite an index catheter ablation[J]. J Cardiovasc Electrophysiol, 2023, 34(12): 2504-2513. DOI: 10.1111/jce.16100.
|
| [25] |
Boixel C, Fontaine V, Rücker-Martin C, et al. Fibrosis of the left Atria during progression of heart failure is associated with increased matrix metalloproteinases in the rat[J]. J Am Coll Cardiol, 2003, 42(2): 336-344. DOI: 10.1016/s0735-1097(03)00578-3.
|
| [26] |
Vitolo M, Proietti M, Imberti J F, et al. Factors associated with progression of atrial fibrillation and impact on all-cause mortality in a cohort of European patients[J]. J Clin Med, 2023, 12(3): 768. DOI: 10.3390/jcm12030768.
|
| [27] |
Ozcan C, Battaglia E, Young R, et al. LKB1 knockout mouse develops spontaneous atrial fibrillation and provides mechanistic insights into human disease process[J]. J Am Heart Assoc, 2015, 4(3): e001733. DOI: 10.1161/JAHA.114.001733.
|
| [28] |
Rudra P, Krishna Krishnamaneni V, Chandan P, et al. Determinants of atrial fibrillation progression and its influence on overall mortality in a cohort of patients from south India[J]. Cureus, 2023, 15(9): e45082. DOI: 10.7759/cureus.45082.
|
| [29] |
Wang H B, Liu M X, Wang X X, et al. MFAP4 deletion attenuates the progression of angiotensin II-induced atrial fibrosis and atrial fibrillation[J]. Europace, 2022, 24(2): 340-347.
|
| [30] |
Bakir E O, Yurdam F S, Dolu A K, et al. The relationship between the left atrium/left ventricle ratio and atrial fibrillation in patients with ischemic stroke without significant left atrial enlargement[J]. Int J Cardiovasc Imaging, 2025, 41(10): 2025-2032. DOI: 10.1007/s10554-025-03512-9.
|